Bangkok Dusit Medical Services Public Company Limited Website

Bangkok Dusit Medical Services Public Company Limited

SET-BDMS

Basic

  • Market Cap

    THB 433.06B

  • EV

    THB 440.46B

  • Shares Out

    15.89B

  • Revenue

    THB 104.73B

  • Employees

Margins

  • Gross

    37.91%

  • EBITDA

    23.89%

  • Operating

    18.75%

  • Pre-Tax

    18.57%

  • Net

    14.3%

  • FCF

    13.19%

Returns (5Yr Avg)

  • ROA

    8.16%

  • ROTA

    12.85%

  • ROE

    12.59%

  • ROCE

    11.11%

  • ROIC

    8.41%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    THB 35.07

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    THB 13.02B

  • Net Debt

    THB 3,667.8M

  • Debt/Equity

    0.16

  • EBIT/Interest

    39.66

Growth (CAGR)

  • Rev 3Yr

    17.62%

  • Rev 5Yr

    5.98%

  • Rev 10Yr

    7.1%

  • Dil EPS 3Yr

    35.78%

  • Dil EPS 5Yr

    0.01%

  • Dil EPS 10Yr

    8.61%

  • Rev Fwd 2Yr

    8.38%

  • EBITDA Fwd 2Yr

    10.66%

  • EPS Fwd 2Yr

    9.82%

  • EPS LT Growth Est

    35%

Dividends

  • Yield

  • Payout

    111.39%

  • DPS

    THB 1.05

  • DPS Growth 3Yr

    24.05%

  • DPS Growth 5Yr

    26.83%

  • DPS Growth 10Yr

    18.04%

  • DPS Growth Fwd 2Yr

    8.02%

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

LTM

Dec '24 (E)

Dec '25 (E)

Dec '26 (E)

Operating Revenues

82,722.6

68,074.1

74,451.3

91,933.6

100,852.6

103,451.7

Other Revenues, Total

1,262.6

1,034

1,257.8

1,275.5

Total Revenues

82,722.6

68,074.1

75,714

92,967.6

102,110.4

104,727.2

Total Revenues % Chg.

6.9%

-17.7%

11.2%

22.8%

9.8%

11.3%

Cost of Goods Sold, Total

54,276.7

46,371.2

49,496.9

58,329.4

63,412.1

65,026

Gross Profit

28,445.9

21,702.9

26,217.1

34,638.3

38,698.3

39,701.2

Selling General & Admin Expenses, Total

17,446.6

14,160.9

14,993.7

17,654.6

19,806

20,066

Other Operating Expenses, Total

17,446.6

14,160.9

14,993.7

17,654.6

19,806

20,066

Operating Income

10,999.4

7,542

11,223.4

16,983.7

18,892.3

19,635.2

Interest Expense, Total

-928.8

-870.9

-728.5

-632.1

-546.6

-495.1

Interest And Investment Income

119.4

44.5

77.7

87.9

216.9

236.2

Net Interest Expenses

-809.4

-826.4

-650.7

-544.1

-329.7

-259

Income (Loss) On Equity Invest.

1,022.4

272.9

21.1

41.8

89.4

68

Other Non Operating Income (Expenses)

1,051.2

983.1

EBT, Excl. Unusual Items

12,263.6

7,971.6

10,593.7

16,481.4

18,652

19,444.3

Gain (Loss) On Sale Of Investments

7,619

2,429

EBT, Incl. Unusual Items

19,882.6

10,400.6

10,593.7

16,481.4

18,652

19,444.3

Income Tax Expense

3,873.5

2,751.4

2,103.4

3,227.2

3,754.5

3,914.7

Earnings From Continuing Operations

16,009.2

7,649.3

8,490.4

13,254.2

14,897.5

15,529.6

Minority Interest

-492

-435

-554.3

-648

-522.2

-548.7

Net Income

15,517.2

7,214.2

7,936.1

12,606.2

14,375.3

14,981

Net Income to Common Incl Extra Items

15,517.2

7,214.2

7,936.1

12,606.2

14,375.3

14,981

Net Income to Common Excl. Extra Items

15,517.2

7,214.2

7,936.1

12,606.2

14,375.3

14,981

Total Shares Outstanding

15,892

15,892

15,892

15,892

15,892

15,892

Weighted Avg. Shares Outstanding

15,742.8

15,892

15,892

15,892

15,892

15,892

Weighted Avg. Shares Outstanding Dil

15,742.8

15,892

15,892

15,892

15,892

15,892

EPS

1

0.5

0.5

0.8

0.9

0.9

EPS Diluted

1

0.5

0.5

0.8

0.9

0.9

EBITDA

16,751.5

13,497.7

17,073.1

22,512

24,337.1

25,020.6

Effective Tax Rate

19.5%

26.5%

19.9%

19.6%

20.1%

20.1%